Talking stock: Sell IDBI Bank; hold Sun Pharma

INSUBCONTINENT EXCLUSIVE:
By G ChokkalingamI have been holding 1,400 shares of IDBI Bank at Rs 112 since 3.5 years
shareholders
Its net NPA at 16 per cent is the highest in the industry and advances de-grew by 16 per cent year-on-year basis, the worst business
performance
Its financial net worth at around Rs 18,000 crore is substantially less than outstanding net NPA of about Rs 29,000 crore as on December 31,
2017. I am holding 12,000 RCom shares at Rs 36
its stock price on account of further monetisation of its assets. I bought VIP Clothing at Rs 88 and 20 Microns at Rs 59.50
for about 3/4th of annualised sales and intangible (invisible) assets is close to three times tangible fixed assets
You may hold 20 Microns with a target price of around 65 considering its valuation and its output, which is used by growing industries. I am
holding few shares of Sun Pharma and Reliance Power
Considering book value and opportunity to reduce debt, Reliance Power could rise to Rs 50 level in the next 1 to 2 years
I believe that large pharma companies including Sun Pharma would come of US FDA issues and get back to growth path from FY2020. I have 2,000
shares of Unitech at Rs 10.14 and 1,500 shares of JP Power at Rs 8.31
them to come to significant profit growth
450 and 100 at Rs 430
Now its trailing at Rs 303
You may average it only if it falls below Rs 250 level. I have 350 shares of HEG, 850 of Graphite India and 400 of Phillips Carbon
The chemicals, which these companies produce are extremely cyclical in nature
In my view, smart investors should start booking profits at the peak of business cycles and re-enter at the bottom of the cycles
Trying to find out the optimum prices for cyclical stocks is very tough job even for seasoned investors. I hold 200 shares of Lupin at an
average rate of Rs 1,265
Please suggest a suitable position
I believe that Lupin would come out of all US regulatory issues quite successfully before the end of FY20, and therefore, the stock would
recover close to your initial cost price within two years. (G Chokkalingam is the Founder of Equinomics Research Advisory)Please send your
queries on Stocks to et.stocks@timesgroup.com; Mutual Funds to et.mfs@timesgroup.com Tax to et.tax@timesgroup.com Insurance to
et.insurance@timesgroup.com Realty to et.realty@timesgroup.com